A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds

NCT07594158 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsy

Interventions

DRUG: Cenobamate (tablet) for 12 to < 18 year olds
DRUG: Cenobamate (syrup) for 2 to < 18 year olds

Sponsor

Ono Pharmaceutical Co., Ltd.